IFIH1 and dermatomyositis: A 2022 multicenter retrospective cohort study in Hong Kong, China, by Ho et al., reported a marked increase in anti-MDA5+ DM-related RP-ILD from October to December, with further analysis implicating infections as a contributing factor to the development of RP-ILD (13).